Hbm Holdings Ltd
HKEX:2142
Hbm Holdings Ltd
Operating Income
Hbm Holdings Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Operating Income
$27.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Operating Income
-HK$106.7m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
Uni-Bio Science Group Ltd
HKEX:690
|
Operating Income
HK$76.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Operating Income
HK$257m
|
CAGR 3-Years
43%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Essex Bio-Technology Ltd
HKEX:1061
|
Operating Income
HK$338.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is Hbm Holdings Ltd's Operating Income?
Operating Income
27.1m
USD
Based on the financial report for Dec 31, 2023, Hbm Holdings Ltd's Operating Income amounts to 27.1m USD.